Author:
Y. Jhansi Lakshmi, B. Umadevi, K. Kranthi Kumar and Y. Suneetha*
Journal Name: Biological Forum, 17(6): 113-121, 2025
Address:
Y. Jhansi Lakshmi, B. Umadevi, K. Kranthi Kumar and Y. Suneetha*
Department of Zoology, Division of Cancer Informatics, Sri Venkateswara University, Tirupati (Andhra Pradesh), India.
(Corresponding author: Y. Suneetha*)
DOI: https://doi.org/10.65041/BiologicalForum.2025.17.6.16
Flavonoids, Molecular docking, Nrf2-Keap1, Antioxidant enzymes, Catalase, Glutathione reductase, Superoxide dismutase, EGCG, ADMET, Oxidative stress modulation.
Oxidative stress has emerged as a central pathological mechanism linked to a range of chronic inflammatory conditions, including reproductive damage (Agarwal et al., 2012). It results from an imbalance between the production of reactive oxygen species (ROS) and the antioxidant defense mechanisms that neutralize them. This imbalance can disrupt cellular homeostasis, damage vital biomolecules, and impair biological functions. Exposure to environmental toxicants such as di-n-butyl phthalate (DBP) is known to enhance ROS production by decreasing antioxidant enzyme activity and increasing lipid peroxidation, particularly affecting testicular function (Zhou et al., 2010).
Among the critical cellular defense mechanisms, the Keap1-Nrf2 signaling axis plays a pivotal role in sensing oxidative stress and initiating protective gene expression (Taguchi & Yamamoto 2021). Under basal conditions, Keap1 binds to Nrf2, retaining it in the cytoplasm and targeting it for degradation. Upon oxidative challenge, this complex dissociates, allowing Nrf2 to translocate into the nucleus, where it activates antioxidant response element (ARE)-driven genes involved in detoxification and redox balance (Ngo and Duennwald 2022; He et al., 2020). This regulatory system is essential for maintaining redox homeostasis and protecting against cellular injury (Chakkittukandiyil et al., 2022).
Natural products, especially flavonoids, have gained attention as potential modulators of the Keap1-Nrf2-ARE pathway. These compounds have shown promising antioxidant properties and therapeutic benefits in various disease models by upregulating cytoprotective genes such as HO-1 and NQO1 (Zhou et al., 2019). Flavonoids exert their effects through multiple signaling pathways, including PI3K/Akt, MAPK, and NF-κB, and may also influence Nrf2 activation via miRNA-mediated regulation (Adinew et al., 2021). However, their bioavailability and capacity to reach target sites remain significant challenges. Importantly, flavonoids also exhibit potential in mitigating oxidative stress induced by endocrine disruptors, which elevate intracellular ROS and contribute to DNA, lipid, and protein damage (Li et al., 2023; Muscolo et al., 2024). While flavonoids often enhance antioxidant enzyme activity, such as SOD, CAT, and GR, some may exhibit pro-oxidant effects at high concentrations or under specific conditions (Procházková et al., 2011; Pérez-Torres et al., 2017). These dual roles underscore the complexity of flavonoid-enzyme interactions and the need for precise characterization.
Mechanistically, flavonoids activate the Nrf2-ARE pathway, leading to increased expression of antioxidant enzymes and bolstered cellular defenses (Mendonca and Soliman 2020). The ARE, a cis-regulatory element in promoter regions of detoxifying genes, is essential for both basal and inducible antioxidant gene expression (Wild and Mulcahy 2020). Studies in Nrf2-deficient mice confirm the central role of Nrf2 in orchestrating ARE-mediated transcription and protecting against oxidative and chemical insults (Singh et al., 2010).
In this study, we aim to investigate the molecular binding mechanisms of selected flavonoids with antioxidant enzymes, with a particular focus on the Keap1-Nrf2 axis. Through this exploration, we seek to identify promising flavonoid candidates for mitigating oxidative stress and countering the toxic effects of endocrine disruptors.
A. Selection and preparation of flavonoids
To explore the molecular interactions between flavonoids and antioxidant enzymes, we selected a panel of structurally diverse flavonoids with well-documented antioxidant properties. Specifically, morin (CID: 5281670), myricetin (CID: 5281672), quercetin (CID: 5280343) and (–)-epigallocatechin-3-gallate (EGCG) (CID: 65064) were chosen for their reported ability to modulate key antioxidant enzymes, catalase (CAT), superoxide dismutase (SOD), and glutathione reductase (GR). The 3D molecular structures of these flavonoids were retrieved from the PubChem database (Kim et al., 2016). Ligand geometries were optimized using the Universal Force Field (UFF) in Open Babel and converted into AutoDock-compatible PDBQT format for docking analysis (Kumar Konidala et al., 2022). Epigallocatechin gallate (EGCG) was used as a reference template due to its well-established role as a natural Nrf2 activator and antioxidant modulator.
B. Protein structure preparation
The crystal structures of target proteins, Nrf2-Keap1 complex (PDB ID: 7OFE) (Narayanan et al., 2022), CAT (PDB ID: 1DGF) (Putnam et al., 2020), GR (PDB ID: 1GSN) (Becker et al., 1998), and SOD (PDB ID: 5YTO) (Manjula et al., 2018) were obtained from the RCSB Protein Data Bank. Structures with resolutions between 1.50–1.90 Å were selected to ensure high-quality docking results. Water molecules and co-crystallized ligands were removed, hydrogen atoms were added, and Gasteiger charges were assigned using UCSF Chimera v1.10.2. All prepared protein models were saved in PDBQT format using AutoDock tools (Bommu et al., 2017).
C. Molecular docking
Molecular docking was performed using AutoDockvinav4 implicated in PyRx virtual screening software v8.0 (Dallakyan & Olson (2014), a validated tool for predicting ligand-protein interactions and estimating binding affinities (Bommu et al., 2017; Kumar Konidala et al., 2022). Grid box parameters were defined to fully enclose the active sites of each enzyme: grid centers were set at X = 50 Å, Y = 50 Å, Z = 50 Å, with box dimensions of 25 × 25 × 25 Å and a spacing of 0.375 Å (Bommu et al., 2017; Kumar Konidala et al., 2022). These configurations were selected to ensure accurate sampling of potential binding poses. The docking protocol included evaluation of ligand binding conformations, affinity scores, and comparison with reference binding sites to ensure reliability.
D. Visualization of protein–ligand interactions
Docked complexes were visualized and analyzed using BIOVIA Discovery Studio Visualizer v24.1.0.23298 to assess the spatial orientation of the ligands, identify interaction types, and determine key amino acid residues involved in binding stabilization.
E. ADME prediction
The pharmacokinetic profiles of all flavonoids were evaluated using the SwissADME web server (http://www.swissadme.ch/) (Daina et al., 2017). Evaluated parameters included: physicochemical properties (molecular weight, hydrogen bond donors/acceptors, TPSA); lipophilicity (XLOGP3); pharmacokinetics, including gastrointestinal (GI) absorption, blood–brain barrier (BBB) permeability, P-glycoprotein (P-gp) substrate status, CYP450 inhibition (CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4), and skin permeation (Log Kp); drug-likeness (Lipinski rule violations, bioavailability score); and medicinal chemistry filters, including PAINS, Brenk alerts, lead-likeness, and synthetic accessibility.
This study employed molecular docking to investigate the binding interactions of three flavonoids, morin, myricetin, and quercetin with key antioxidant enzymes: Nrf2-Keap1, superoxide dismutase (SOD), catalase (CAT), and glutathione reductase (GR). To provide a comparative benchmark, the binding profiles of these flavonoids were evaluated against epigallocatechin gallate (EGCG), a well-characterized natural Nrf2 activator.
A. Binding mode of flavonoids with Nrf2-Keap1
Binding energies were calculated as –6.9 kcal/mol for morin, –6.7 kcal/mol for myricetin and quercetin, while EGCG exhibited a superior binding energy of –7.6 kcal/mol, serving as a reference Nrf2 activator (Table 1).
Morin showed a binding energy of –6.9 kcal/mol and established key hydrogen bonds with Ser363, Arg380, and Asn382, with interaction distances ranging from 2.47 to 3.92 Å. Notably, the Arg380 and Ala556 residues participated in Pi-alkyl interactions, contributing to the hydrophobic stabilization of the complex (Fig. 1a). These interactions suggest a moderately stable binding conformation within the Nrf2 pocket.
Myricetin demonstrated a comparable binding energy of –6.7 kcal/mol and engaged in multiple hydrogen bonding interactions with Ser363, Ser555, and Asn382, spanning a range of hydrogen bond lengths (2.42–3.91 Å). Additionally, Pi-alkyl interactions involving Arg380 and Ala556 supported further stabilization (Fig. 1b). The presence of multiple polar contacts indicates a higher degree of specificity in the myricetin binding mode compared to morin.
Quercetin also bound with a docking score of –6.7 kcal/mol. It formed hydrogen bonds with Arg415, Ser555, and Ser602, as well as prominent electrostatic and aromatic interactions, including Pi-Pi T-shaped (Tyr525), Pi-cation (Arg415), and Pi-alkyl (Ala556) (Fig. 1c). These interactions suggest a diverse binding mechanism that may influence the conformational flexibility of the Nrf2 domain.
The reference compound EGCG displayed the most favorable binding energy of –7.6 kcal/mol. It engaged in a hydrogen bond with Ser602 and showed extensive aromatic interactions with Tyr334, Tyr525, Ala556, and Tyr572, including Pi-Pi stacking and T-shaped orientations, consistent with high-affinity binding and Nrf2 activation potential (Fig. 1d). Across all flavonoid complexes, the Ala556 residue emerged as a recurrent site for hydrophobic (Pi-alkyl or Pi-Pi) interactions, suggesting its importance in ligand recognition. Residues such as Arg380, Ser363, and Tyr525 played key roles in forming stabilizing hydrogen and electrostatic contacts. Although all three flavonoids demonstrated moderate affinity toward Nrf2, EGCG's higher binding energy and more diverse interaction profile underline its superior activation capability.
B. Binding mode of flavonoids with catalase (CAT)
Molecular docking analyses revealed favorable binding affinities of the selected flavonoids with catalase (PDB ID: 1DGF). The binding energies were calculated as –8.3 kcal/mol for morin, –8.6 kcal/mol for myricetin, and –8.7 kcal/mol for quercetin, while the reference compound EGCG exhibited the most stable interaction with a binding energy of –8.9 kcal/mol (Table 2).
Morin showed significant binding to CAT through multiple hydrophobic and aromatic interactions. Notable Pi-alkyl contacts were observed with Pro151 and Arg203, while Pi–Pi stacking and T-shaped interactions occurred with Phe198 and Phe446, indicating aromatic ring engagement within the enzyme’s active site. A Pi-cation interaction with Arg203:NH2 (4.29 Å) further stabilized the complex (Fig. 1e). No classical hydrogen bonding was observed, suggesting a predominantly hydrophobic mode of binding.
Myricetin demonstrated enhanced binding affinity with one hydrogen bond involving Arg203 (3.06 Å; 111.01°). This interaction was complemented by extensive aromatic stacking and alkyl contacts, including Pi–Pi stacking with Phe198 and Phe446, Pi-T-shaped interactions, and Pi-cation bonding with Arg203:NH2. Additional Pi-alkyl interactions with Pro151, Arg203, Val302, and His305 contributed to the overall stabilization of the complex (Fig. 1f).
Quercetin showed the strongest binding among the three flavonoids (–8.7 kcal/mol), stabilized by three conventional hydrogen bonds with Ser201 and Tyr215, with bond lengths between 2.02 and 2.61 Å. These polar contacts were reinforced by Pi-stacking and Pi-cation interactions with Phe198, Arg203, Phe446, and His305 (Fig. 1g). The hydrophobic and electrostatic environment contributed significantly to the complex stability and orientation within the catalytic pocket.
EGCG, displayed the most favorable binding energy (–8.9 kcal/mol). It formed a network of six hydrogen bonds with Phe198, Ser201, Arg203, Tyr215, and His305, indicating strong polar interactions. These were complemented by Pi-cation and Pi-alkyl interactions with Arg203 and Phe198 (Fig. 1h), establishing a robust and stable binding conformation.
Overall, Phe198 and Arg203 consistently participated in aromatic and cationic interactions, highlighting their critical role in ligand anchoring within the CAT binding pocket. The presence of Pi–Pi stacking, Pi-cation, and Pi-alkyl contacts, particularly with flavonoid aromatic rings, underscores the significance of hydrophobic interactions in catalase modulation (Vernon et al., 2018). Notably, quercetin and EGCG displayed stronger and more diverse interaction profiles, suggesting potential superiority in enhancing CAT activity or stabilization.
C. Binding mode of flavonoids with glutathione reductase (GR)
Molecular docking studies revealed that the flavonoids Morin, Myricetin, and Quercetin exhibited binding energies of –7.1, –7.2, and –7.2 kcal/mol, respectively, with Glutathione Reductase (PDB ID: 1GSN), while the reference compound EGCG showed a slightly stronger binding energy of –7.4 kcal/mol (Table 3). The interaction profiles of these compounds suggest distinct yet overlapping binding mechanisms.
Morin formed two hydrogen bonds, one with Lys66 (1.97 Å, 154.25°) and another with Val370 (2.88 Å, 140.94°). Additionally, it engaged in hydrophobic interactions, including a π-sulfur contact with Cys63 and π-alkyl interactions with Lys67 and Pro340. A π–π T-shaped interaction with Phe372 further stabilized the complex (Fig. 1i), indicating that Morin binds effectively through a combination of hydrogen bonding and aromatic interactions.
Myricetin formed three hydrogen bonds, involving Cys63 and Lys66 through both its carbon and terminal amino groups, with bond distances ranging from 1.95 to 3.18 Å. It also engaged in π-alkyl interactions with Lys67 and Pro340 and a π–π T-shaped interaction with Phe372 (Fig. 1j). These interactions suggest that Myricetin is stabilized predominantly through polar contacts and non-polar stacking, particularly involving Lys66.
Similarly, Quercetin showed a strong hydrogen bond with Lys66 (1.98 Å, 154.44°), and shared interaction patterns with Morin, including π-sulfur bonding with Cys63 and π-alkyl and π–π T-shaped contacts with Lys67, Pro340, and Phe372 (Fig. 1k). The structural similarity in binding between Myricetin and Quercetin suggests they may share comparable inhibitory potential.
EGCG displayed the most complex binding pattern among all compounds, forming five hydrogen bonds with Ser30, Arg37 (three interactions), and Tyr106, with distances between 2.01 and 2.92 Å. In addition, EGCG exhibited π-cation and π-alkyl interactions with Arg203 and Val64, and π–π stacking with Tyr114 (Fig. 1l). These multiple interactions are likely responsible for its stronger binding affinity.
Overall, key residues such as Cys63, Lys66, Lys67, Pro340, and Phe372 were consistently involved in π-sulfur, π-alkyl, and π–π interactions across all complexes. The diversity and complementarity of hydrogen bonding and hydrophobic interactions indicate a robust and flexible binding cavity within GR that accommodates these flavonoids (Patil et al., 2010). These findings suggest that the antioxidant activity of these compounds may, in part, be attributed to their capacity to modulate GR function by stabilizing its catalytic domain and potentially interfering with glutathione metabolism.
D. Binding mode of flavonoids with superoxide dismutase (SOD)
Molecular docking studies demonstrated that Morin, Myricetin, and Quercetin bind to Superoxide Dismutase (SOD; PDB ID: 5YTO) with comparable binding energies of –7.2, –7.1, and –7.2 kcal/mol, respectively, while the reference compound EGCG exhibited a stronger binding energy of –7.7 kcal/mol. The interaction profiles reveal that these flavonoids engage the active site of SOD through a combination of hydrogen bonds, π-interactions, and hydrophobic contacts, primarily involving residues such as Glu21, Lys23, and Lys30.
Morin established a conventional hydrogen bond with Lys23 (2.74 Å, 107.57°), and hydrophobic interactions dominated its binding profile. These included π-anion and amide–π stacking with Glu21 and Lys23, respectively, and alkyl interactions with Lys23 and Lys30 (Fig. 1m). These multiple interactions highlight the role of cationic and acidic residues in anchoring the ligand through aromatic ring stacking and electrostatic interactions.
Myricetin formed three hydrogen bonds with Thr2 (2.47–2.71 Å) and Glu100 (2.69 Å), indicating strong polar contacts with both N-terminal and loop-region residues. Its hydrophobic interactions included π-alkyl and π-anion contacts with Lys3 and Glu21, along with π-sigma interactions with Lys23 and additional alkyl stacking with Lys30 (Fig. 1n). This suggests that Myricetin engages in a more dispersed interaction network, stabilizing its binding conformation through both edge-on and face-on stacking geometries.
Quercetin mirrored Morin’s binding profile with hydrogen bonds formed via Lys23 and Glu100, and several π-interactions including π-anion with Glu21 and amide–π stacking and alkyl contacts with Lys23 and Lys30 (Fig. 1o). These overlapping interaction modes between Morin and Quercetin indicate potential redundancy or synergy in their antioxidant action via SOD modulation.
EGCG showed the most complex interaction pattern. It formed five hydrogen bonds with Glu21, Gln22, and Pro28 (distances ranging from 1.95–2.42 Å), establishing a robust hydrogen bond network. Furthermore, EGCG exhibited multiple hydrophobic and π-based interactions involving Lys23, Pro28, Lys30, and Glu100 (Fig. 1p). Notably, π-anion and amide–π stacking with Glu100 and Lys23 reinforced the binding strength, correlating with its highest docking score.
Overall, residues such as Glu21, Lys23, Lys30, and Glu100 recurrently appeared across all flavonoid complexes, playing essential roles in hydrogen bonding, π-interactions, and hydrophobic contacts. The interplay of these dynamic interactions suggests that flavonoid binding induces a conformational flexibility in SOD, potentially stabilizing its structure and modulating its enzymatic function (Kamel et al., 2025). This structural stabilization may hinder the formation or regulation of reactive oxygen species (ROS), underlining the antioxidant potential of these phytochemicals through SOD inhibition or modulation.
E. ADMET and medicinal chemistry profile analysis
The pharmacokinetic and drug-likeness profiles of Morin, Myricetin, Quercetin, and EGCG were assessed using the SwissADME tool (http://www.swissadme.ch/index.php) to evaluate their potential as bioavailable antioxidants.
Morin and Quercetin showed optimal molecular weight (302.24 g/mol), moderate TPSA (131.36 Ų), and favorable hydrogen bonding profiles, indicating good membrane permeability. EGCG, with the highest MW (458.37 g/mol), TPSA (197.37 Ų), and H-bond donors/acceptors, exhibited poor absorption potential. LogP values for all compounds were in the moderate range (1.17–1.54), supporting balanced lipophilicity (Table 5).
GI absorption was high for Morin and Quercetin but low for Myricetin and EGCG. None of the compounds were BBB permeant or P-gp substrates, minimizing CNS toxicity and efflux concerns. EGCG showed the least skin permeability due to its large polar surface (Table 5).
CYP inhibition analysis revealed that Morin and Quercetin inhibited CYP1A2, CYP2D6, and CYP3A4, suggesting drug interaction risks. Myricetin inhibited two CYPs, while EGCG showed no CYP inhibition, indicating metabolic safety despite low absorption (Table 5).
All compounds largely met Lipinski’s rules, except EGCG, which had two violations and the lowest bioavailability score (0.17). Morin and Quercetin were most favorable, with no rule violations and better oral drug-likeness. Synthetic accessibility was acceptable for all, though EGCG was slightly more complex. PAINS and Brenk alerts were absent in Morin, but present in the others, pointing to fewer structural liabilities for Morin (Table 5).
Overall, Morin and Quercetin emerged as the most promising candidates for further development based on their favorable ADMET and medicinal chemistry profiles.
Fig. 1. Molecular interaction profiles of selected flavonoids (morin, myricetin, quercetin, and EGCG) with antioxidant targets. Visualizations illustrate binding orientations, key hydrogen bonds, and hydrophobic or π-based interactions within the active sites of Nrf2-Keap1, CAT, GR, and SOD.
Table 1: Binding energy and key molecular interactions of flavonoids and EGCG with the Nrf2 receptor.
Ligand | Binding energy (kcal/mol) | Hydrogen bond interactions | Hydrophobic, electrostatic and other interactions | |||||
Interactions (Protein-----Ligand) | Distance (Å) | Angle (º) | Interactions (Residues) | Type | Distance(Å) | Angle (º) | ||
5281670 (Morin) | -6.9 | Ser363:OG-----H Arg380:CD-----O Asn382:ND2Pi-H | 2.47 3.67 3.92 | 96.54 46.76 36.53 | Arg380 Ala556 | Pi-Alkyl Pi-Alkyl | 5.46 4.06 | - |
5281672 (Myricetin) | -6.7 | Ser363:O - H Ser363:OG - H Asn382:ND2Pi-H Ser555:HG - O Ser555:HG - O | 2.85 2.56 3.91 2.42 2.55 | 101.32 90.14 35.85 119.08 109.09 | Arg380 Ala556 | Pi-Alkyl Pi-Alkyl | 5.40 4.18 | - |
5280343 (Quercetin) | -6.7 | Arg415:CD - O Arg415:NH2 - O Ser555:HG - O Ser602:HG - O | 3.76 3.34 2.48 3.02 | 42.14 45.14 95.73 97.23 | Tyr525 Arg415 Ala556 | Pi-Pi T-shaped Pi-Cation Pi-Alkyl | 5.15 4.96 4.50 | 25.06 24.16 - |
65064 (EGCG) | -7.6 | Ser602:HGPi-H | 3.42 | 36.06 | Tyr334 Tyr525 Ala556 Tyr572 Tyr572 | Pi-Pi Stacked Pi-Pi T-shaped Pi-Alkyl Pi-Pi T-shaped Pi-Alkyl | 4.47 4.91 5.33 5.40 4.86 | 27.33 13.57 - 10.98 - |
Table 2: Molecular docking-derived binding energies and key interactions of flavonoids with catalase (CAT).
Ligand | Binding energy (kcal/mol) | Hydrogen bond interactions | Hydrophobic and Electrostatic interactions | |||||
Interactions (Protein-----Ligand) | Distance (Å) | Angle (º) | Interactions (Residues) | Type | Distance(Å) | Angle (º) | ||
5281670 (Morin) | -8.3 | - | - | - | Pro151 Phe198 Phe198 Phe198 Arg203 Arg203:NH2 Val302 Phe446 | Pi-Alkyl Pi-Pi Stacked Pi-Pi Stacked Pi-Pi T-shaped Pi-Alkyl Pi-Cation Pi-Alkyl Pi-Pi T-shaped | 5.13 4.56 5.54 4.95 4.58 4.29 4.43 4.76 | - 48.50 70.85 68.15 - 24.51 - 78.62 |
5281672 (Myricetin) | -8.6 | Arg203:H-----O | 3.06 | 111.01 | Pro151 Phe198 Phe198 Phe198 Arg203:NH2 Arg203 Val302 His305 Phe446 | Pi-Alkyl Pi-Pi Stacked Pi-Pi Stacked Pi-Pi T-shaped Pi-Cation Pi-Alkyl Pi-Alkyl Pi-Pi Stacked Pi-Pi T-shaped | 5.08 4.60 5.68 4.85 4.28 4.65 4.40 5.69 4.76 | - 50.23 71.38 66.29 22.53 - - 40.74 77.26 |
5280343 (Quercetin) | -8.7 | Ser201:HG-----O Ser201:HG-----O Tyr215:HN-----O | 2.02 2.22 2.61 | 130.17 119.81 99.67 | Pro151 Phe198 Phe198 Phe198 Arg203:NH2 Arg203 Val302 His305 Phe446 | Pi-Alkyl Pi-Pi Stacked Pi-Pi Stacked Pi-Pi T-shaped Pi-Cation Pi-Alkyl Pi-Alkyl Pi-Pi Stacked Pi-Pi T-shaped | 5.08 4.60 5.70 4.83 4.29 4.67 4.39 5.69 4.74 | - 50.418 71.445 65.295 21.253 - - 40.622 77.174 |
65064 EGCG | -8.9 | Phe198:O-----N Ser201:HG-----OC Arg203:HH-----OC Arg203:O-----N Tyr215:HH-----O His305:CE1-----O | 2.68 2.42 2.69 2.01 2.71 3.36 | 112.21 158.90 101.39 165.15 103.38 20.51 | Arg203 Phe198 Arg203 Arg203 | Pi-Cation Pi-Alkyl Pi-Alkyl Pi-Alkyl | 4.02 4.72 5.39 3.99 | - |
Table 3: Docking-based interaction profiles of flavonoids with glutathione reductase (GR).
Ligand | Binding energy (kcal/mol) | Hydrogen bond interactions | Hydrophobic, electrostatic and other interactions | |||||
Interactions (Protein-----Ligand) | Distance (Å) | Angle (º) | Interactions (Residues) | Type | Distance(Å) | Angle (º) | ||
5281670 (Morin) | -7.1 | Lys66:HZ1-----O Val370:OC-----N | 1.97 2.88 | 154.25 140.94 | Cso63:SG Lys67 Pro340 Phe372 | Pi-Sulfur Pi-Alkyl Pi-Alkyl Pi-Pi T-shaped | 4.30 3.93 5.09 5.17 | 22.44 - - 74.36 |
5281672 (Myricetin) | -7.2 | Cso63:OC-----N Lys66:CE-----O Lys66:HZ1-----O | 2.31 3.18 1.95 | 145.16 52.41 159.97 | Lys67 Pro340 Phe372 | Pi-Alkyl Pi-Alkyl Pi-Pi T-shaped | 3.96 5.02 5.20 | - |
5280343 (Quercetin) | -7.2 | Lys66:HZ1-----O | 1.98 | 154.44 | Cso63:SG Lys67 Pro340 Phe372 | Pi-Sulfur Pi-Alkyl Pi-Alkyl Pi-Pi T-shaped | 4.32 3.93 5.09 5.16 | 22.78 - - 74.32 |
65064 (EGCG) | -7.4 | Ser30:CO-----N Arg37:HH-----O Arg37:HH-----O Arg37:HH-----O Tyr106:HH-----O | 2.67 2.92 2.16 2.84 2.46 | 163.86 91.40 141.10 131.77 101.66 | Ala34 Ile343 Val64 Tyr114 | Pi-Alkyl Pi-Sigma Pi-Alkyl Pi-Pi Stacked | 5.20 3.96 5.45 5.42 | - 21.484 - 59.86 |
Table 4: Molecular docking interaction summary of flavonoids with superoxide dismutase (SOD).
Ligand | Binding energy (kcal/mol) | Hydrogen bond interactions | Hydrophobic, electrostatic and other interactions | |||||
Interactions (Protein-----Ligand) | Distance (Å) | Angle (º) | Interactions (Residues) | Type | Distance(Å) | Angle (º) | ||
5281670 (Morin) | -7.2 | Lys23:HN-----O | 2.74 | 107.57 | Glu21 Lys23 Lys23 Lys23 Lys30 | Pi-Anion Amide-Pi Stacked Alkyl Alkyl Alkyl | 3.71 4.12 5.02 5.13 4.09 | 25.26 24.77 - - - |
5281672 (Myricetin) | -7.1 | Thr2:HG1-----O Thr2:HG1-----O Glu100:OE2-----H | 2.71 2.47 2.69 | 109.19 127.09 115.61 | Lys3 Glu21 Lys23 Lys23 Lys30 | Pi-Alkyl Pi-Anion Pi-Sigma Pi-Alkyl Pi-Alkyl | 5.30 4.65 3.41 4.89 5.06 | - 34.30 4.01 - - |
5280343 (Quercetin) | -7.2 | Lys23:HN-----O Glu100:OE2-----H | 2.76 2.18 | 107.38 147.41 | Glu21 Lys23 Lys23 Lys23 Lys30 | Pi-Anion Amide-Pi Stacked Pi-Alkyl Pi-Alkyl Pi-Alkyl | 3.72 4.11 5.01 5.09 4.05 | 22.80 25.39 - - - |
*65064 (EGCG) | -7.7 | Glu21:OE1-----H Gln22:HN-----O Pro28:O-----H | 1.95 2.42 2.30 | 159.55 116.82 131.36 | Lys23 Lys23 Lys23 Pro28 Lys30 Lys30 Glu100 | Amide-Pi Stacked Pi-Alkyl Pi-Alkyl Pi-Alkyl Alkyl Pi-Alkyl Pi-Anion | 4.20 4.44 3.85 4.26 4.10 4.17 4.79 | 30.667 - - - - - 27.674 |
Table 5: Predicted physicochemical properties, pharmacokinetics (ADME), and drug-likeness profiles of morin, myricetin, quercetin, and EGCG.
Category | Property | Morin | Myricetin | Quercetin | EGCG |
Physicochemical | Molecular Weight (MW) | 302.24 | 318.24 | 302.24 | 458.37 |
Fraction Csp³ | 0 | 0 | 0 | 0.14 | |
Rotatable Bonds | 1 | 1 | 1 | 4 | |
H-bond Acceptors | 7 | 8 | 7 | 11 | |
H-bond Donors | 5 | 6 | 5 | 8 | |
Molar Refractivity (MR) | 78.03 | 80.06 | 78.03 | 112.06 | |
Topological Polar Surface Area (TPSA) | 131.36 | 151.59 | 131.36 | 197.37 | |
XLOGP3 (logP) | 1.54 | 1.18 | 1.54 | 1.17 | |
Absorption | GI Absorption | High | Low | High | Low |
Distribution | BBB Permeant | No | No | No | No |
P-gp Substrate | No | No | No | No | |
Metabolism | CYP1A2 Inhibitor | Yes | Yes | Yes | No |
CYP2C19 Inhibitor | No | No | No | No | |
CYP2C9 Inhibitor | No | No | No | No | |
CYP2D6 Inhibitor | Yes | No | Yes | No | |
CYP3A4 Inhibitor | Yes | Yes | Yes | No | |
Excretion(inferred) | Log Kp (skin permeability, cm/s) | –7.05 | –7.4 | –7.05 | –8.27 |
Medicinal Chemistry | Lipinski Rule Violations (#) | 0 | 1 | 0 | 2 |
Bioavailability Score | 0.55 | 0.55 | 0.55 | 0.17 | |
PAINS Alerts (#) | 0 | 1 | 1 | 1 | |
Brenk Alerts (#) | 0 | 1 | 1 | 1 | |
Leadlikeness Violations (#) | 0 | 0 | 0 | 1 | |
Synthetic Accessibility (0–10) | 3.25 | 3.27 | 3.23 | 4.20 |
Adinew, G. M., Taka, E., Mendonca, P., Messeha, S. S. and Soliman, K. F. (2021). The anticancer effects of flavonoids through miRNAs modulations in triple-negative breast cancer. Nutrients, 13(4), 1212.
Agarwal, A., Aponte-Mellado, A., Premkumar, B. J., Shaman, A. and Gupta, S. (2012). The effects of oxidative stress on female reproduction: a review. Reproductive biology and endocrinology, 10, 1-31.
Becker, K., Savvides, S. N., Keese, M., Schirmer, R. H. and Karplus, P. A. (1998). Enzyme inactivation through sulfhydryl oxidation by physiologic NO-carriers. Nature Structural Biology, 5(4), 267-271.
Bommu, U. D., Konidala, K. K., Pabbaraju, N. and Yeguvapalli, S. (2017). Ligand-based virtual screening, molecular docking, QSAR and pharmacophore analysis of quercetin-associated potential novel analogs against epidermal growth factor receptor. Journal of Receptors and Signal Transduction, 37(6), 600-610.
Chakkittukandiyil, A., Sajini, D. V., Karuppaiah, A. and Selvaraj, D. (2022). The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease. Neurochemistry International, 156, 105325.
Daina, A., Michielin, O. and Zoete, V. (2017). SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific reports, 7(1), 42717.
Dallakyan, S. and Olson, A. J. (2014). Small-molecule library screening by docking with PyRx. In Chemical biology: methods and protocols (pp. 243-250). New York, NY: Springer New York.
He, F., Ru, X. and Wen, T. (2020). NRF2, a transcription factor for stress response and beyond. International journal of molecular sciences, 21(13), 4777.
Kamel, E. M., Othman, S. I., Rudayni, H. A., Allam, A. A. and Lamsabhi, A. M. (2025). Multi-pronged molecular insights into flavonoid-mediated inhibition of squalene epoxidase: a pathway to novel therapeutics. RSC advances, 15(5), 3829-3848.
Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A. and Bryant, S. H. (2016). PubChem substance and compound databases. Nucleic acids research, 44(D1), D1202-D1213.
Kumar Konidala, K., Bommu, U. and Pabbaraju, N. (2022). Integration of in silico methods to determine endocrine-disrupting tobacco pollutants binding potency with steroidogenic genes: Comprehensive QSAR modeling and ensemble docking strategies. Environmental Science and Pollution Research, 29(43), 65806-65825.
Lee, J. M., Calkins, M. J., Chan, K., Kan, Y. W. and Johnson, J. A. (2003). Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. Journal of Biological Chemistry, 278(14), 12029-12038.
Li, X., Zang, N., Zhang, N., Pang, L., Lv, L., Meng, X. and Leng, J. (2023). DNA damage resulting from human endocrine disrupting chemical exposure: Genotoxicity, detection and dietary phytochemical intervention. Chemosphere, 338, 139522.
Manjula, R., Wright, G. S., Strange, R. W. and Padmanabhan, B. (2018). Assessment of ligand binding at a site relevant to SOD 1 oxidation and aggregation. FEBS letters, 592(10), 1725-1737.
Mendonca, P. and Soliman, K. F. (2020). Flavonoids activation of the transcription factor Nrf2 as a hypothesis approach for the prevention and modulation of SARS-CoV-2 infection severity. Antioxidants, 9(8), 659.
Muscolo, A., Mariateresa, O., Giulio, T. and Mariateresa, R. (2024). Oxidative stress: the role of antioxidant phytochemicals in the prevention and treatment of diseases. International journal of molecular sciences, 25(6), 3264.
Narayanan, D., Tran, K. T., Pallesen, J. S., Solbak, S. M., Qin, Y., Mukminova, E. and Bach, A. (2022). Development of noncovalent small-molecule Keap1-Nrf2 inhibitors by fragment-based drug discovery. Journal of medicinal chemistry, 65(21), 14481-14526.
Ngo, V. and Duennwald, M. L. (2022). Nrf2 and oxidative stress: A general overview of mechanisms and implications in human disease. Antioxidants, 11(12), 2345.
Patil, R., Das, S., Stanley, A., Yadav, L., Sudhakar, A. and Varma, A. K. (2010). Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing. PloS one, 5(8), e12029.
Pérez-Torres, I., Guarner-Lans, V. and Rubio-Ruiz, M. E. (2017). Reductive stress in inflammation-associated diseases and the pro-oxidant effect of antioxidant agents. International journal of molecular sciences, 18(10), 2098.
Procházková, D., Boušová, I. and Wilhelmová, N. (2011). Antioxidant and prooxidant properties of flavonoids. Fitoterapia, 82(4), 513-523.
Putnam, C. D., Arvai, A. S., Bourne, Y. and Tainer, J. A. (2000). Active and inhibited human catalase structures: ligand and NADPH binding and catalytic mechanism. Journal of molecular biology, 296(1), 295-309.
Singh, S., Vrishni, S., Singh, B. K., Rahman, I. and Kakkar, P. (2010). Nrf2-ARE stress response mechanism: a control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases. Free Radical Research, 44(11), 1267-1288.
Taguchi, K., and Yamamoto, M. (2020). The KEAP1–NRF2 system as a molecular target of cancer treatment. Cancers, 13(1), 46.
Vernon, R. M., Chong, P. A., Tsang, B., Kim, T. H., Bah, A., Farber, P. and Forman-Kay, J. D. (2018). Pi-Pi contacts are an overlooked protein feature relevant to phase separation. elife, 7, e31486.
Wild, A. C. and Mulcahy, R. T. (2000). Regulation of γ-glutamylcysteinesynthetase subunit gene expression: insights into transcriptional control of antioxidant defenses. Free radical research, 32(4), 281-301.
Zhou, D., Wang, H., Zhang, J., Gao, X., Zhao, W. and Zheng, Y. (2010). Di-n-butyl phthalate (DBP) exposure induces oxidative damage in testes of adult rats. Systems Biology in Reproductive Medicine, 56(6), 413-419.
Y. Jhansi Lakshmi, B. Umadevi, K. Kranthi Kumar and Y. Suneetha (2025). Comparative Docking and Pharmacokinetic Insights into Flavonoid Modulation of Antioxidant Enzymes: A Molecular Basis for Nrf2 Activation and Oxidative Stress Mitigation. Biological Forum, 17(6): 113-121.